SCHEMBL5246359

SCHEMBL5246359

O=C1[CH]C(=O)SCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9084507 0.91 ALDH1A1 (0.32)
SCHEMBL7170234 0.68
SCHEMBL675775 0.68
SCHEMBL1819740 0.67
SCHEMBL6027741 0.66 ALDH1A1 (0.47)
Thiobutyrolactone SCHEMBL1021969 0.64
Thiobutyrolactone SCHEMBL13480 0.64
SCHEMBL1026886 0.63
SCHEMBL1024257 0.62
SCHEMBL133712 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817032-A2 MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmaceuticals Incorporated (US) 2007-08-15 EP claimed
WO-2006058294-A2 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-01 WO claimed
WO-2013047904-A1 AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING HARMFUL ARTHROPODS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-04 WO disclosed
WO-2012133861-A1 DIENE AMIDES AND THEIR USE AGAINST ARTHROPODS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-04 WO disclosed
EP-1817032-A2 MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmaceuticals Incorporated (US) 2007-08-15 EP disclosed
WO-2006058294-A2 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-01 WO disclosed